SILO

Silo Pharma (SILO)

Silo Pharma Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:SILO

<< 이전 1 2 3 4 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/06/21	22:00	GlobeNewswire Inc.	Silo Pharma’s SPU-21 Treatment for Autoimmune Disease Awarded U.S. Patent	NASDAQ:SILO	Silo Pharma Inc
2023/06/13	21:05	GlobeNewswire Inc.	Silo Pharma Signs Agreement to Develop First-in-Class Ketamine Implant Therapeutic	NASDAQ:SILO	Silo Pharma Inc
2023/06/02	21:50	GlobeNewswire Inc.	Silo Pharma Announces Participation on Webull Corporate Communications Service Platform	NASDAQ:SILO	Silo Pharma Inc
2023/05/30	22:00	GlobeNewswire Inc.	Silo Pharma Commences Study of Novel Joint Homing Peptide SPU-21	NASDAQ:SILO	Silo Pharma Inc
2023/05/27	05:20	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SILO	Silo Pharma Inc
2023/05/19	05:21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SILO	Silo Pharma Inc
2023/05/09	21:05	GlobeNewswire Inc.	Silo Pharma’s SPC-15 Awarded U.S. Patent Protecting Ongoing R&D of Therapeutic for Stress-Induced Affective Disorder and Alzheimer’s Disease	NASDAQ:SILO	Silo Pharma Inc
2023/04/24	21:15	GlobeNewswire Inc.	Silo Pharma to Present at Psychedelic Drug Development Conference	NASDAQ:SILO	Silo Pharma Inc
2023/04/19	22:00	GlobeNewswire Inc.	Silo Pharma Commences Formulation for SPC-15 Targeting Anxiety and PTSD Stress-Related Disorders	NASDAQ:SILO	Silo Pharma Inc
2023/03/27	22:00	GlobeNewswire Inc.	Silo Pharma Announces filing of Patent for Treatment of Fibromyalgia	NASDAQ:SILO	Silo Pharma Inc
2023/03/15	21:40	GlobeNewswire Inc.	Silo Pharma Announces Positive Results from IND-Enabling Study of SP-26 for Fibromyalgia	NASDAQ:SILO	Silo Pharma Inc
2023/02/16	06:17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SILO	Silo Pharma Inc
2023/02/15	06:01	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:SILO	Silo Pharma Inc
2023/02/13	22:35	GlobeNewswire Inc.	Silo Pharma Announces Filing of Patent for Treatment of Alzheimer’s	NASDAQ:SILO	Silo Pharma Inc
2023/02/03	22:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SILO	Silo Pharma Inc
2023/02/02	22:50	GlobeNewswire Inc.	Silo Pharma Announces Expansion of Intellectual Property Portfolio	NASDAQ:SILO	Silo Pharma Inc
2023/02/01	06:16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SILO	Silo Pharma Inc
2023/01/31	21:45	GlobeNewswire Inc.	Silo Pharma Announces Stock Repurchase Program	NASDAQ:SILO	Silo Pharma Inc
2023/01/20	22:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SILO	Silo Pharma Inc
2023/01/11	00:15	GlobeNewswire Inc.	Silo Pharma Advances Clinical Study Analyzing Effects of Psilocybin on Inflammation	NASDAQ:SILO	Silo Pharma Inc
2022/12/30	22:10	GlobeNewswire Inc.	Silo Pharma Announces Positive Study Results of SPU- 21 for Arthritis	NASDAQ:SILO	Silo Pharma Inc
2022/12/16	06:16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SILO	Silo Pharma Inc
2022/12/02	06:17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SILO	Silo Pharma Inc
2022/12/01	23:00	GlobeNewswire Inc.	Silo Pharma Issues Letter to Shareholders Detailing Progress on Pipeline Assets Combining Traditional Therapeutics with Psychedelic Medicine	NASDAQ:SILO	Silo Pharma Inc
2022/11/21	21:45	GlobeNewswire Inc.	Silo Pharma Initiates Study of Novel Joint Homing Peptide in Human Tissue	NASDAQ:SILO	Silo Pharma Inc
2022/11/11	22:15	GlobeNewswire Inc.	Silo Pharma Achieves New Milestone for SP-26 Therapeutic -Initiates IND Enabling Study of Topical Ketamine Formulation	NASDAQ:SILO	Silo Pharma Inc
2022/11/11	06:49	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:SILO	Silo Pharma Inc
2022/10/26	22:00	GlobeNewswire Inc.	Silo Pharma to Discuss Mainstream Pharma and Psychedelics at Wonderland Miami Conference	NASDAQ:SILO	Silo Pharma Inc
2022/10/20	21:05	GlobeNewswire Inc.	Silo Pharma Announces Data Supporting Therapeutic Potential of SPC-14 for Alzheimer’s Disease in Pre-Clinical Study	NASDAQ:SILO	Silo Pharma Inc
2022/10/19	06:16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SILO	Silo Pharma Inc